William C. Campbell (scientist)

Last updated

William C. Campbell
William C. Campbell 4983-1-2015.jpg
Campbell in Stockholm, December 2015
Born
William Cecil Campbell

(1930-06-28) 28 June 1930 (age 93)
Ramelton, County Donegal, Ireland
NationalityIrish, American
Alma mater Trinity College Dublin
University of Wisconsin
Known for Avermectin
Awards Nobel Prize in Physiology or Medicine (2015)
Scientific career
Fields Parasitic diseases
Institutions Merck Institute for Therapeutic Research
Drew University
Thesis Fascioloides magna (trematoda) with special reference to the adult in relation to disease  (1957)

William Cecil Campbell (born 28 June 1930) is an Irish biologist and parasitologist with United States citizenship, known for his work in discovering a novel therapy against infections caused by roundworms, for which he was jointly awarded the 2015 Nobel Prize in Physiology or Medicine. [1] He helped to discover a class of drugs called avermectins, whose derivatives have been shown to have "extraordinary efficacy" in treating River blindness and Lymphatic filariasis, among other parasitic diseases affecting animals and humans. [2] Campbell worked at the Merck Institute for Therapeutic Research 1957–1990, and is currently a research fellow emeritus at Drew University. [3] [4]

Contents

Biography

With Satoshi Omura (left), Stockholm, December 2015 Satoshi Omura 4977-2015.jpg
With Satoshi Ōmura (left), Stockholm, December 2015

Campbell was born in Ramelton, County Donegal, Ireland in 1930, [5] the third son of R. J. Campbell, a farm supplier. He studied at Trinity College, Dublin with James Desmond Smyth, [6] graduating in 1952 with first class honours in Zoology. He then attended the University of Wisconsin–Madison on a Fulbright Scholarship, earning his PhD degree in 1957 for work on the liver fluke, a parasite affecting sheep. [4]

From 1957 to 1990 Campbell worked at Merck Institute for Therapeutic Research, [7] and from 1984 to 1990 he was a Senior Scientist and Director with Assay Research and Development. He became a US citizen in 1964. [8] One of his discoveries while at Merck was the fungicide thiabendazole, used to treat potato blight, historically a scourge of Ireland. [4] [9] Thiabendazole is also used to treat trichinosis in humans. [10]

Campbell is best known for his work on parasitic diseases. Japanese microbiologist Satoshi Ōmura isolated and cultured many varieties of natural soil-based bacteria from the group Streptomyces. Campbell led a team at Merck in studying Ōmura's cultures and examining their effectiveness in treating parasites in domestic and farm animals. From a sample of Streptomyces avermitilis , naturally occurring in soil, he derived a macrocyclic lactone. After further modification, it was named ivermectin (generic) or Mectizan. [11]

In 1978, having identified a successful treatment for a type of worms affecting horses, Campbell realised that similar treatments might be useful against related types of worms that affect humans. In 1981, Merck carried out successful Phase 1 treatment trials in Senegal and France on river blindness. [2] [12] Taken orally, the drug paralyses and sterilises the parasitic worm that causes the illness. [13] Merck went on to study the treatment of elephantiasis. The research of Satoshi Ōmura, William Campbell, and their co-workers created a new class of drugs for the treatment of parasites. [2] [12]

In 1987, Merck decided to donate Ivermectin (Mectizan) to developing countries. [13] Campbell was instrumental in that decision. [7] [14] With the World Health Organization they created an "unprecedented" drug donation program, with the intention of wiping out river blindness. [13] As of 2001 an estimated 25 million people were being treated each year, in a total of 33 countries in sub-Saharan Africa, Latin America, and the Middle East. [12] [15] [16] [17] As of 2013, the Carter Center's International Task Force for Disease Eradication independently verified that the disease had been eradicated in Colombia, Ecuador, and Mexico. [18]

The greatest challenge for science is to think globally, think simply and act accordingly. It would be disastrous to neglect the diseases of the developing world. One part of the world affects another part. We have a moral obligation to look after each other, but we're also naturally obligated to look after our own needs. It has to be both. [6]

From 1990 to 2010, when he retired, Campbell was a research fellow at Drew University in Madison, N.J., where he supervised undergraduate research and taught courses in parasitology. [12] He has written about the history of parasitology in Antarctic exploration, including the work of surgeon Edward L. Atkinson in Scott's ill-fated Terra Nova Expedition. [7] [19]

In 2002, Campbell was elected member of the United States National Academy of Sciences. [20] In 2015, he and Satoshi Ōmura shared half of the 2015 Nobel Prize in Physiology or Medicine for their research on therapies against infections caused by roundworm parasites, using derivatives of avermectin. [2] [21] Campbell is the seventh Irish person to be awarded a Nobel Prize, including Ernest Walton who was awarded the Nobel Prize in Physics in 1951 [6] and Samuel Beckett for Literature in 1968. [22]

Personal life

William C. Campbell is married to Mary Mastin Campbell. [7] He is a published poet and painter. [23] His recreational activities include table tennis and kayaking. [6]

Awards and honours

Related Research Articles

<span class="mw-page-title-main">Scabies</span> Human disease

Scabies is a contagious human skin infestation by the tiny (0.2–0.45 mm) mite Sarcoptes scabiei, variety hominis. The word is from Latin: scabere, lit. 'to scratch'. The most common symptoms are severe itchiness and a pimple-like rash. Occasionally, tiny burrows may appear on the skin. In a first-ever infection, the infected person usually develops symptoms within two to six weeks. During a second infection, symptoms may begin within 24 hours. These symptoms can be present across most of the body or just certain areas such as the wrists, between fingers, or along the waistline. The head may be affected, but this is typically only in young children. The itch is often worse at night. Scratching may cause skin breakdown and an additional bacterial infection in the skin.

<span class="mw-page-title-main">Nobel Prize in Physiology or Medicine</span> One of five Nobel Prizes established in 1895 by Alfred Nobel

The Nobel Prize in Physiology or Medicine is awarded yearly by the Nobel Assembly at the Karolinska Institute for outstanding discoveries in physiology or medicine. The Nobel Prize is not a single prize, but five separate prizes that, according to Alfred Nobel's 1895 will, are awarded "to those who, during the preceding year, have conferred the greatest benefit to humankind". Nobel Prizes are awarded in the fields of Physics, Chemistry, Physiology or Medicine,Economics Literature and Peace.

<span class="mw-page-title-main">Onchocerciasis</span> Human helminthiasis (infection by parasite)

Onchocerciasis, also known as river blindness, is a disease caused by infection with the parasitic worm Onchocerca volvulus. Symptoms include severe itching, bumps under the skin, and blindness. It is the second-most common cause of blindness due to infection, after trachoma.

<span class="mw-page-title-main">Filariasis</span> Parasitic disease caused by a family of nematode worms

Filariasis is a parasitic disease caused by an infection with roundworms of the Filarioidea type. These are spread by blood-feeding insects such as black flies and mosquitoes. They belong to the group of diseases called helminthiases.

The year 1930 in science and technology involved some significant events, listed below.

<i>Artemisia annua</i> Herb known as sweet wormwood used to treat malaria

Artemisia annua, also known as sweet wormwood, sweet annie, sweet sagewort, annual mugwort or annual wormwood, is a common type of wormwood native to temperate Asia, but naturalized in many countries including scattered parts of North America.

<span class="mw-page-title-main">Artemisinin</span> Group of drugs used against malaria

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Artemisinin-based combination therapies (ACTs) are now standard treatment worldwide for P. falciparum malaria as well as malaria due to other species of Plasmodium. Artemisinin is extracted from the plant Artemisia annua a herb employed in Chinese traditional medicine. A precursor compound can be produced using a genetically engineered yeast, which is much more efficient than using the plant.

<span class="mw-page-title-main">Abamectin</span> Insecticide and anti-parasitic worm chemical

Abamectin (also called avermectin B1) is a widely used insecticide and anthelmintic. Abamectin, is a member of the avermectin family and is a natural fermentation product of soil dwelling actinomycete Streptomyces avermitilis. Abamectin differs from ivermectin, the popular member of the avermectin family, by a double bond between carbons 22 and 25. Fermentation of Streptomyces avermitilis yields eight closely related avermectin homologs, with the B1a and B1b forms comprising the majority of the fermentation. The non-proprietary name, abamectin, refers to a mixture of B1a (~80%) and B1b (~20%). Out of all the avermectins, abamectin is the only one that is used both in agriculture and pharmaceuticals.

<span class="mw-page-title-main">Ivermectin</span> Medication for parasite infestations

Ivermectin is an antiparasitic drug. After its discovery in 1975, its first uses were in veterinary medicine to prevent and treat heartworm and acariasis. Approved for human use in 1987, it is used to treat infestations including head lice, scabies, river blindness (onchocerciasis), strongyloidiasis, trichuriasis, ascariasis and lymphatic filariasis. It works through many mechanisms to kill the targeted parasites, and can be taken by mouth, or applied to the skin for external infestations. It belongs to the avermectin family of medications.

<span class="mw-page-title-main">Strongyloidiasis</span> Medical condition

Strongyloidiasis is a human parasitic disease caused by the nematode called Strongyloides stercoralis, or sometimes the closely related S. fülleborni. These helminths belong to a group of nematodes called roundworms. These intestinal worms can cause a number of symptoms in people, principally skin symptoms, abdominal pain, diarrhea and weight loss, but also many other specific and vague symptoms in disseminated disease, and severe life-threatening conditions through hyperinfection. In some people, particularly those who require corticosteroids or other immunosuppressive medication, Strongyloides can cause a hyperinfection syndrome that can lead to death if untreated. The diagnosis is made by blood and stool tests. The medication ivermectin is widely used to treat strongyloidiasis.

The American Society of Pharmacognosy (ASP) is a scientific society that promotes the growth and development of pharmacognosy through presentation of research achievements and publication of meritorious research.

<span class="mw-page-title-main">Avermectin</span> Drugs to treat parasitic worms and insect pests

The avermectins are a series of drugs and pesticides used to treat parasitic worm infestations and to reduce insect pests. They are a group of 16-membered macrocyclic lactone derivatives with potent anthelmintic and insecticidal properties. These naturally occurring compounds are generated as fermentation products by Streptomyces avermitilis, a soil actinomycete. Eight different avermectins were isolated in four pairs of homologue compounds, with a major (a-component) and minor (b-component) component usually in ratios of 80:20 to 90:10. Avermectin B1, a mixture of B1a and B1b, is the drug and pesticide abamectin. Other anthelmintics derived from the avermectins include ivermectin, selamectin, doramectin, eprinomectin.

<i>Mansonella perstans</i> Species of roundworm

Mansonella perstans is a filarial (arthropod-borne) nematode (roundworm), transmitted by tiny blood-sucking flies called midges. Mansonella perstans is one of two filarial nematodes that causes serous cavity filariasis in humans. The other filarial nematode is Mansonella ozzardi. M. perstans is widespread in many parts of sub-Saharan Africa, parts of Central and South America, and the Caribbean.

<span class="mw-page-title-main">Kitasato University</span> Medical university in Tokyo, Japan

Kitasato University is a private medical university headquartered in Shirokane, Minato, Tokyo, Japan. The head of the university is on the Shirokane campus, neighboring the original Kitasato Institute, the first private medical research facility in Japan which was the starting point for the university in its present form.

<span class="mw-page-title-main">Emamectin</span> Chemical compound

Emamectin is the 4″-deoxy-4″-methylamino derivative of abamectin, a 16-membered macrocyclic lactone produced by the fermentation of the soil actinomycete Streptomyces avermitilis. It is generally prepared as the salt with benzoic acid, emamectin benzoate, which is a white or faintly yellow powder. Emamectin is widely used in the US and Canada as an insecticide because of its chloride channel activation properties.

<span class="mw-page-title-main">Merck & Co.</span> American multinational pharmaceutical company

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical companies in the world, generally ranking in the global top five by revenue.

<span class="mw-page-title-main">Tu Youyou</span> Chinese pharmaceutical chemist (born 1930)

Tu Youyou is a Chinese malariologist and pharmaceutical chemist. She discovered artemisinin and dihydroartemisinin, used to treat malaria, a breakthrough in twentieth-century tropical medicine, saving millions of lives in South China, Southeast Asia, Africa, and South America.

<span class="mw-page-title-main">American Society of Parasitologists</span>

Founded in 1924, the American Society of Parasitologists comprises a diverse group of about 700 scientists from academia, industry, and government involved in the study and teaching of the scientific discipline of parasitology. Society members contribute to the development of parasitology as a discipline, as well as to primary research in behavior, biochemistry, ecology, immunology, medicine, molecular biology, physiology, systematics, and other related fields of science.

<span class="mw-page-title-main">Satoshi Ōmura</span> Japanese biochemist

Satoshi Ōmura is a Japanese biochemist. He is known for the discovery and development of hundreds of pharmaceuticals originally occurring in microorganisms. In 2015, he was awarded the Nobel Prize in Physiology or Medicine jointly with William C. Campbell for their role in the discovery of avermectins and ivermectin, the world's first endectocide and a safe and highly effective microfilaricide. It is believed that the large molecular size of ivermectin prevents it from crossing the blood/aqueous humour barrier, and renders the drug an important treatment of helminthically-derived blindness.

<span class="mw-page-title-main">Japan Pharmaceutical Association</span>

The Japan Pharmaceutical Association is the peak national professional association representing pharmacists in Japan. Pharmacists who join their prefectural and local municipality professional organisations automatically gain membership in the JPA. The association was founded on June 11, 1893 by Ogimachi Sanemasa.

References

  1. "William C Campbell, Satoshi Ōmura and Youyou Tu win Nobel prize in medicine". The Guardian. 5 October 2015. Retrieved 5 October 2015.
  2. 1 2 3 4 "The 2015 Nobel Prize in Physiology or Medicine – Press Release: William C. Campbell, Satoshi Ōmura, Youyou Tu". Nobel Foundation. Retrieved 8 December 2015.
  3. Molin, Anna (5 October 2015). "Nobel Prize in Physiology or Medicine Awarded to William C. Campbell, Satoshi Omura, Youyou Tu". The Wall Street Journal. Retrieved 5 October 2015.
  4. 1 2 3 Scott, Dermot. "William C. Campbell (Sc.D.)". Ramelton Tidy Towns. Archived from the original on 11 April 2013. Retrieved 9 December 2015.
  5. "William C. Campbell – Facts". Nobel Prize. Retrieved 24 September 2016.
  6. 1 2 3 4 Murphy, Darragh (9 October 2015). "Meet Ireland's new Nobel Laureate, William C Campbell". The Irish Times . Retrieved 13 October 2015.
  7. 1 2 3 4 5 6 7 Overstreet, Robin M. (2008). "Presentation of the 2008 ASP Distinguished Service Award to William C. Campbell". Journal of Parasitology. 94 (6): 1209. doi:10.1645/GE-1852.1. PMID   18844434. S2CID   20359861 . Retrieved 9 December 2015.
  8. "Prof. William Campbell, of NJ, wins Nobel Prize in medicine". News 12 New Jersey . Associated Press. 5 October 2015. Archived from the original on 8 October 2015. Retrieved 6 October 2015.
  9. Annual Report on Research and Technical Work of the Department of Agriculture for Northern Ireland. Great Britain: The Department of Agriculture for Northern Ireland. 1975. p. 149.
  10. Jelliffe, E. F. Patrice; Jelliffe, Derrick B. (1982). Adverse Effects of Foods. Boston, MA: Springer US. p. 277. ISBN   978-1-4613-3361-6 . Retrieved 9 December 2015.
  11. "History". Merck & Co., Inc.
  12. 1 2 3 4 Avril, Tom (6 October 2015). "Former Merck scientist shares Nobel in medicine". Philadelphia Inquirer. Retrieved 8 December 2015.
  13. 1 2 3 "Merck Offers Free Distribution of New River Blindness Drug". The New York Times. 22 October 1987. Retrieved 8 December 2015.
  14. Siddall, Mark (13 October 2015). "A Noble and Laudable Nobel Laureate: William C. Campbell". HuffPost. Retrieved 9 December 2015.
  15. Sturchio, Jeffrey L (2001). "The Case of Ivermectin: Lessons and Implications for Improving Access to Care and Treatment in Developing Countries". Community Eye Health. 14 (38): 22–23. PMC   1705916 . PMID   17491909.
  16. "African Programme for Onchocerciasis Control (APOC)". World Health Organization. Archived from the original on 6 August 2008. Retrieved 8 December 2015.
  17. "MORE THAN 25 Years: The MECTIZAN® Donation Program". Merck Be Well. Retrieved 8 December 2015.
  18. Damico, Kathleen (29 October 2015). "Nobel Laureate Dr. William C. Campbell: A man of character, passion and art". PRWeb. Retrieved 9 December 2015.
  19. Campbell, William C.; Overstreet, Robin M. (1994). "Historical Basis of Binomials Assigned to Helminths Collected on Scott's Last Antarctic Expedition" (PDF). Journal of the Helminthological Society of Washington. 61 (1): 1–11. Retrieved 9 December 2015.
  20. "Member Directory | William Campbell". National Academy of Sciences. Retrieved 5 October 2015.
  21. "Irish scientist wins Nobel Prize for Medicine". RTÉ News. 5 October 2015. Retrieved 5 October 2015.
  22. "Samuel Beckett – Facts". www.nobelprize.org. Retrieved 3 April 2018.
  23. "Dr. William Campbell: Nobel Laureate, Painter, Actor, Writer". Drew University. Archived from the original on 14 December 2020. Retrieved 9 December 2015.
  24. "TRINITY MONDAY 2016- FELLOWS AND SCHOLARS". www.tcd.ie. Trinity College Dublin. 11 April 2016. Retrieved 27 January 2022.
  25. "William C. Campbell". Royal Society. Retrieved 19 September 2020.
  26. "William Campbell and Vincent Roche win St Patrick's Day Science Medals". 16 March 2021.